Share This
Rituximab
Rituximab, sold under the trade names Rituxan and MabThera, is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of B cells. Rituximab is used in the treatment of many lymphomas, leukemias, and some autoimmune disorders.
Rituximab was developed by IDEC...
Learn more about Rituximab »
Add More Topics
Save this view to a base, or just for yourself.
2 Technology class topics matching:
Filter this Collection
+
Monoclonal Antibody
Monoclonal antibodies (mAb or moAb) are monospecific antibodies that are identical because they are produced by one type of immune cell that are all clones of a single parent cell. Given almost any substance, it is possible to create monoclonal...
BV user with expertise:
Parent Technology:
Products involving this technology:
View entire collection »
Chimeric Monoclonal Antibody
Chimeric mABs are constructed from murine variable regions with the constant domain of human IgG.
